POP Pharma
Board
2 directors, no change since 2023Director (not named in the articles)
since 25-10-2010
term without a fixed end
earlier director, until 14-12-2023
listed in the 2025 annual accounts, filed on 29-06-2026
Director (not named in the articles)
appointed by deed of 18-03-2014
term without a fixed end
earlier director, until 14-12-2023
listed in the 2025 annual accounts, filed on 29-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”deed of 14-12-2023
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager (not named in the articles), from 25-10-2010 to 14-12-2023
- Director (not named in the articles), since before 14-12-2023
-
- Manager, appointed by deed of 18-03-2014, until 14-12-2023
- Director (not named in the articles), since before 14-12-2023
Control
Founder
This company
POP Pharma
Equity €962,646
Profit €269,974 in 2025
Capital
- Contribution
- €18,600
- Shares
- 100 in the deed of 25-11-2010
- Source
- 2025 annual accounts
Articles of association
deed of 14-12-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Voor helft ten laste overdrager en helft ten laste koper(s) naar evenredigheid verworven aantal bij meerdere kopers, nietigheid
- Share issue ruleThe articles set how and by whom new shares are issued.
- Ten minste vijftien dagen te rekenen van dag openstelling intekening, eerst aan bestaande aandeelhouders naar evenredigheid aantal aandelen
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June at 20:00
Shareholders
At incorporation
deed of 25-11-2010 ↗
- 100 shares (100%) · €5,000
Capital transactions
Capital over time
- 14-12-2023 Converted to unavailable equity · €20,460
- 18-03-2014 Capital increase of €13,600 · to €18,600 · from reserves
- 25-11-2010 Incorporation · €5,000 · 100 shares